Evaluation of MRX PT DOAC as a new screening method for detecting interferences in thrombophilia analyses​Kerstin Arbring Mikael Lund Liselotte Onelöv Tomas L. Lindahl a Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Swedenb Department of Acute Internal Medicine and Geriatrics, County Council of Östergötland, Linköping, Swedenc Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Swedend Department of Internal Medicine, Motala Hospital, Motala, Swedene Nordic Biomarker AB, Umeå, Swedenon January 24, 2025 at 5:51 am